Mirum Pharmaceuticals Inc (MIRM)
108.62
+1.06%
Mirum Pharmaceuticals Inc (MIRM) is currently trading at $108.62. This represents a gain of 1.06% from the previous session. With a market capitalization of $5.61B, MIRM is a key component of the Health Care sector. Investors looking to trade MIRM should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade MIRM commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Mirum Pharmaceuticals Inc (MIRM) shows a bullish trend. Analysts are watching the 109.05 level closely.
Fundamentals
Mkt Cap5.61B
P/E Ratio0.0000
Volume649,037
60-Day Technical Chart
Advanced Charting
Need more indicators for MIRM? Use the world's #1 platform.
Open MIRM on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $109
| Metric |
MIRM +1.06% |
CRWV -1.30% |
NOW +1.70% |
C +4.36% |
|---|---|---|---|---|
| Price | $108.62 | $98.01 | $104.23 | $114.34 |
| Mkt Cap | $5.61B | $51.09B | $109.02B | $200.02B |
| - | View → | View → | View → |
Latest Headlines
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Powerhouse with 9.63% Potential Upside
DirectorsTalk Interviews • Feb 25, 2026
Rare disease company Mirum lines up March investor talks online
Stock Titan • Feb 23, 2026
Mirum Pharmaceuticals (MIRM): Assessing Valuation After Strong Long-Term Returns and Recent Share Price Pullback
Yahoo Finance • Dec 11, 2025
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
Business Wire • Feb 5, 2026
Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal'
Stocktwits • Dec 8, 2025
● Gemini Agentic AI Analyst Insight for MIRM
Market Education
- Are Cruise Stocks Finally Back on Course After a Rocky Five Years? Sep 27, 2025
- Money manifesting videos - POS and used by Nutcases Jul 16, 2023
- Institutions vs Retail Traders - Showdown, Apes are winning May 24, 2021
External Research